SG3 Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-90,000
Closed -$14.7M 276
2022
Q3
$14.7M Buy
+90,000
New +$15.2M 1.97% 10
2022
Q2
Sell
-64,100
Closed -$11.4M 610
2022
Q1
$11.4M Buy
64,100
+60,000
+1,463% +$10.2M 0.32% 70
2021
Q4
$701K Buy
+4,100
New +$671K 0.01% 558
2020
Q3
Sell
-7,500
Closed -$1.05M 974
2020
Q2
$1.05M Sell
7,500
-7,400
-50% -$1.08M 0.07% 277
2020
Q1
$1.95M Sell
14,900
-115,100
-89% -$16.3M 0.26% 70
2019
Q4
$19M Buy
+130,000
New +$17.6M 1.18% 10
2019
Q2
Sell
-67,500
Closed -$9.44M 462
2019
Q1
$9.44M Buy
67,500
+50,000
+286% +$6.7M 0.93% 30
2018
Q4
$2.26M Buy
+17,500
New +$2.44M 0.58% 44
2017
Q3
Sell
-48,400
Closed -$6.4M 214
2017
Q2
$6.4M Buy
+48,400
New +$6.17M 1.6% 12

Other funds holding JNJ

SG3 Management's JNJ Position: Q2 2022 in Review

SG3 Management sold out of Johnson & Johnson (JNJ) in Q2 2022, closing a stake of 6,000 shares — an estimated $1.06M sold.

SG3 Management first reported a position in JNJ in Q4 2019 and held it in 3 quarters. The position peaked at $2.52M in Q4 2019. 3,671 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

  • SG3 Management reported no remaining Johnson & Johnson position as of Q2 2022 after selling out during the quarter.
  • SG3 Management sold 6,000 Johnson & Johnson shares in Q2 2022, an estimated $1.06M.
  • SG3 Management first reported a position in Johnson & Johnson in Q4 2019 and held it in 3 quarters.
  • SG3 Management's Johnson & Johnson position peaked at $2.52M in Q4 2019.
  • 3,671 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.